Characterization of Human Memory Immune Responses to Prior Yellow Fever Vaccination

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-11-30

Study Completion Date

2029-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to study immune memory generated against the yellow fever (YFV) vaccine in participants who have previously received the vaccine. Volunteers will not receive vaccine shots; only immune responses to previous yellow fever vaccination will be studied. The study involves one or multiple blood draws.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Complementary Study of the Duration of Post-vaccination Against Yellow Fever Immunity in Children

NCT02990182

Yellow Fever

UNKNOWN

Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV

NCT01190228

Japanese Encephalitis Varicella

COMPLETED PHASE3

Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in Frequent Platelets Donors

NCT04224311

Preventive Immunization; Meningitis

UNKNOWN PHASE4

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

NCT00262015

Meningococcal Disease; Meningococcal Meningitis

UNKNOWN PHASE4

Can we Reduce the Number of Vaccine Injections for Children?

NCT01129518

Invasive Meningococcal Disease

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this study is to characterize immune memory in humans who have previously received yellow fever vaccine. The project is designed to study the magnitude and persistence of both humoral, and cell-mediated immune memory generated post-vaccination. Since aging has an effect on the immune system (eg. decreased thymic output, replacement of hematopoietic cells in the bone marrow with adipocytes), the researchers will analyze the young adults (aged 18-45 years) and the older vaccinees (55 years or older) in separate groups.

The specific aims of the study are to:

* Determine the phenotypic and functional characterization of memory T cell responses to yellow fever vaccination
* Determine neutralizing antibody titer after yellow fever vaccination

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Yellow Fever Vaccine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1: 18 to 45 years of age

Between the ages of 18 and 45 at the time of yellow fever vaccination

No interventions assigned to this group

Group 2: 55 years of age and above

Aged 55 or greater at the time of yellow fever vaccination

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Able to understand and give informed consent
* Age 18-45 years (Group 1) or 55 years and above (Group 2) at the time of yellow fever vaccination
* Documentation (international certificate of vaccination (yellow card) or medical record) indicating receipt of yellow fever vaccine.

Exclusion Criteria

* Recipient of any vaccines within 30 days before the study visit (not applicable to older adults)
* History of a progressive and severe chronic medical condition resulting in impaired immunity (such as diabetes, kidney or liver dysfunction)
* Required use of immunosuppressive medications
* Reporting HIV, Hepatitis B (surface antigen positive) or Hepatitis C infections (antibody positive) on the medical/health history form
* Recipient of a blood product or immune globulin product within 42 days of study visit
* Reporting pregnancy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes